Crescita Therapeutics Inc. (CRRTF.PK,CTX.TO), Monday announced its first-quarter financial results, reporting a net loss of C$1.160 million, or C$0.06 a share, compared to C$0.932 million, or C$0.05 a share, last year.
Operating loss amounted to C$1.2 million compared to C$1.1 million in the earlier year.
Revenues increased to C$5.6 million from C$3.5 million in the prior year.
Crescita's stock closed trading at $0.5731 on the OTC Markets on Friday.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.